Evidence map›Paper›PMID 34532717›Full record

ArticleJAMA health forum2020

Colorectal Cancer Screening and Prevention in the COVID-19 Era.

Rachel B Issaka, Ma Somsouk

Abstract read
In one paragraph

Article in JAMA health forum, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021
    Pooled it
  2. Article
  3. Article
  4. Impact of the COVID-19 Pandemic on Cancer Screening Delays.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Real-World Data on the Impact of COVID-19 on Endoscopic Procedural Delays.Clinical and translational gastroenterology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rachel B IssakaClinical Research Division, Fred Hutchinson Cancer Research Center. Seattle, WA. USA.
Ma SomsoukDivision of Gastroenterology, University of California, San Francisco. San Francisco, CA.

Funding

Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approachK08CA241296 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ISSAKA, RACHEL B. · 2019 to 2023
$1.1M
NCI NIH HHS K08 CA241296NIMHD NIH HHS L32 MD012892
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsCOVID-19Early Detection of CancerHumansSARS-CoV-2

Identifiers

PMID34532717
PMCPMC8443218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.